Astellas Pharma Inc (ALPMY)

$10.07 +0.50 (5.22%)
Market Cap 17.32B
Revenue (ttm) 10.62B
Net Income (ttm) 113.00M
EPS (ttm) N/A
PE Ratio 12.37
Forward PE 15.56
Profit Margin 1.06%
Debt to Equity Ratio 0.61
Volume 152,700
Avg Vol 193,804
Day's Range N/A - N/A
Shares Out 1.81B
Stochastic %K 98%
Beta 0.31
Analysts Sell
Price Target $11.30

Latest News on ALPMY

No data available.